Quarterly report [Sections 13 or 15(d)]

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2023   8,311,237    
Beginning balance at Dec. 31, 2023 $ 15,273 $ 1 $ 318,600 $ (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   126,305    
Stock-based compensation (670)   (670)  
Net loss (24,050)     (24,050)
Ending balance (in shares) at Mar. 31, 2024   8,437,542    
Ending balance at Mar. 31, 2024 (9,447) $ 1 317,930 (327,378)
Beginning balance (in shares) at Dec. 31, 2023   8,311,237    
Beginning balance at Dec. 31, 2023 15,273 $ 1 318,600 (303,328)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (49,317)      
Ending balance (in shares) at Jun. 30, 2024   8,574,249    
Ending balance at Jun. 30, 2024 (32,839) $ 1 319,805 (352,645)
Beginning balance (in shares) at Mar. 31, 2024   8,437,542    
Beginning balance at Mar. 31, 2024 (9,447) $ 1 317,930 (327,378)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   136,707    
Stock-based compensation 1,875   1,875  
Net loss (25,267)     (25,267)
Ending balance (in shares) at Jun. 30, 2024   8,574,249    
Ending balance at Jun. 30, 2024 $ (32,839) $ 1 319,805 (352,645)
Beginning balance (in shares) at Dec. 31, 2024 8,656,122 8,656,122    
Beginning balance at Dec. 31, 2024 $ (100,500) $ 1 322,729 (423,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for PIPE Investment, net of issuance costs (in shares)   1,771,586    
Issuance of common stock for PIPE Investment, net of issuance costs 3,477   3,477  
Deemed dividend to Series A Preferred Stock (403)   (403)  
Vesting of restricted stock units, net (in shares)   215,260    
Stock-based compensation 647   647  
Net loss (37,675)     (37,675)
Ending balance (in shares) at Mar. 31, 2025   10,642,968    
Ending balance at Mar. 31, 2025 $ (134,454) $ 1 326,450 (460,905)
Beginning balance (in shares) at Dec. 31, 2024 8,656,122 8,656,122    
Beginning balance at Dec. 31, 2024 $ (100,500) $ 1 322,729 (423,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (59,252)      
Ending balance (in shares) at Jun. 30, 2025 21,784,277 21,784,277    
Ending balance at Jun. 30, 2025 $ (132,722) $ 2 349,758 (482,482)
Beginning balance (in shares) at Mar. 31, 2025   10,642,968    
Beginning balance at Mar. 31, 2025 (134,454) $ 1 326,450 (460,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Conversion of Series A Preferred Stock to common stock (in shares)   10,728,414    
Conversion of Series A Preferred Stock to common stock 21,408 $ 1 21,407  
Vesting of restricted stock units, net (in shares)   412,895    
Vesting of restricted stock units, net and payment of minimum employee taxes withheld upon net share settlement of restricted stock units (536)   (536)  
Stock-based compensation 2,437   2,437  
Net loss $ (21,577)     (21,577)
Ending balance (in shares) at Jun. 30, 2025 21,784,277 21,784,277    
Ending balance at Jun. 30, 2025 $ (132,722) $ 2 $ 349,758 $ (482,482)